Alexion cuts collaborations with Moderna Therapeutics, Blueprint Medicines and Arbutus Biopharma
Medtech companies can provide the tools to empower patients and HCPs.
Addressing the needs of patients with low health literacy.
20/06/2017June 1, 2017
‘Pricing and Market Access Outlook: 2017 Edition’ includes fresh analysis from QuintilesIMS of market forces and pricing policy based on facts and figures behind approvals of new molecular entities in 2015.